Cargando…

Statins Neuromuscular Adverse Effects

Statins are drugs widely prescribed in high-risk patients for cerebrovascular or cardiovascular diseases and are, usually, safe and well tolerated. However, these drugs sometimes may cause neuromuscular side effects that represent about two-third of all adverse events. Muscle-related adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attardo, Silvia, Musumeci, Olimpia, Velardo, Daniele, Toscano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369175/ https://www.ncbi.nlm.nih.gov/pubmed/35955495 http://dx.doi.org/10.3390/ijms23158364

Ejemplares similares

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
por: Camerino, Giulia Maria, et al.
Publicado: (2021)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

S2.3 Therapeutic approaches in the late onset form of GSD II
por: Musumeci, Olimpia, et al.
Publicado: (2011)

Early is better? A new algorithm for early diagnosis in Late Onset Pompe Disease (LOPD)
por: TOSCANO, ANTONIO, et al.
Publicado: (2013)

Molecular Genetics Overview of Primary Mitochondrial Myopathies
por: Arena, Ignazio Giuseppe, et al.
Publicado: (2022)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study
por: Camerino, Giulia M., et al.
Publicado: (2017)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects
por: Lupica, Antonino, et al.
Publicado: (2022)

A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies
por: Musumeci, Olimpia, et al.
Publicado: (2020)

Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects
por: Pancheri, Elia, et al.
Publicado: (2020)

Mitochondrial Disease (MELAS Syndrome) Discovered at the Start of Pregnancy in a Patient with Advanced CKD: A Clinical and Ethical Challenge
por: Santoro, Domenico, et al.
Publicado: (2019)

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
por: Yow, Hui-Yin, et al.
Publicado: (2023)

Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
por: Sharma, Priyadarshani, et al.
Publicado: (2019)

Pleotropic effects of statins: the dilemma of wider utilization of statin
por: Choudhary, Ambika, et al.
Publicado: (2023)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
por: Mo, Huanbiao, et al.
Publicado: (2019)

The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease
por: Iyer, Shama R., et al.
Publicado: (2021)

Pleiotropic effects of statins
por: Kavalipati, Narasaraju, et al.
Publicado: (2015)

Phenotyping Adverse Drug Reactions: Statin-Related Myotoxicity
por: Wiley, Laura K., et al.
Publicado: (2015)

Are pleiotropic effects of statins real?
por: Corsini, Alberto, et al.
Publicado: (2007)

Effects of statins on mitochondrial pathways
por: Mollazadeh, Hamid, et al.
Publicado: (2021)

Statin-Associated Necrotizing Autoimmune Myositis Complicated by an Uncommon Adverse Effect to Treatment
por: Fung, Brian M., et al.
Publicado: (2019)

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023)

Impact of COVID‐19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy
por: Gagliardi, Delia, et al.
Publicado: (2021)

Perioperative protective effects of statins
por: Singh, Nina, et al.
Publicado: (2010)

Effects of Statins on Cardiorenal Syndrome
por: Yagi, Shusuke, et al.
Publicado: (2012)

Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
por: Doshi, Peter, et al.
Publicado: (2022)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

Statins and cancers
por: Stryjkowska-Góra, Aleksandra, et al.
Publicado: (2014)

Immunosuppression-related neurological disorders in kidney transplantation
por: Faravelli, Irene, et al.
Publicado: (2021)

A Comprehensive Review on Multifaceted Mechanisms Involved in the Development of Breast Cancer Following Adverse Childhood Experiences (ACEs)
por: Pino, Olimpia, et al.
Publicado: (2022)

Tetracyclines and Neuromuscular Disorders
por: Orsucci, Daniele, et al.
Publicado: (2012)

Neuromuscular Disorders
por: Nair, Muralidharan
Publicado: (2019)

Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita
por: Portaro, Simona, et al.
Publicado: (2015)

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
por: Parisi, Daniela, et al.
Publicado: (2018)

Neuromuscular Junction as an Entity of Nerve-Muscle Communication
por: Lepore, Elisa, et al.
Publicado: (2019)

Novel Effects of Statins on Cancer via Autophagy
por: Mengual, Daniela, et al.
Publicado: (2022)

Ongoing Clinical Trials of the Pleiotropic Effects of Statins
por: Davignon, Jean, et al.
Publicado: (2005)

Pleiotropic vasoprotective effects of statins: The chicken or the egg?
por: Kirmizis, Dimitrios, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lc3c5u2c86g1a41v54oua1nc4p